Part of the global response strategy against the COVID pandemic involves the administration of booster shots ... BNL received consulting fees from Sanofi and GSK and holds stock options from ...

GSK and Sanofi think they could ... at preventing severe COVID-19 disease and asymptomatic infection. With an eye on countries' emerging plans for booster shots, the two companies will also ...

Kennedy, known as a persistent critic of vaccine safety and a booster of conspiracy theories, said it is a possibility he ...

Predicting which people with inflammatory rheumatic musculoskeletal diseases (I-RMDs) may experience flares after COVID-19 ...

Another key objective is to find vaccines that can provide longer-lasting protection, so people do not need to have a booster shot every ... of the technology in COVID-19 vaccines, the NIAID ...

The Gaithersburg biotech is preparing to turn over sales activity for its only product to its commercial partner. Novavax Inc. has made a smaller splash in the U.S. Covid-19 vaccine market than it ...

Sanofi (Symbol: SNY) presently has an above average rank, in the top 50% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.

Fewer health care workers are getting the most recent COVID-19 booster. Findings from a new survey by the Centers for Disease ...

If you belong to one of these groups, the Advisory Committee on Immunization Practices now recommends getting a 2024-2025 ...

During the Covid-19 pandemic, the French government made pledges to restore self-sufficiency in healthcare. Labour unions last week called for strike action at Sanofi's plants in France over fears ...